A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder (Q38467955)
Jump to navigation
Jump to search
scientific article published on June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder |
scientific article published on June 2012 |
Statements
1 reference
A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder (English)
1 reference
Earle E Bain
1 reference
George Apostol
1 reference
R Bart Sangal
1 reference
Weining Z Robieson
1 reference
Dawnelle L McNeill
1 reference
Walid M Abi-Saab
1 reference
Mario D Saltarelli
1 reference
1 June 2012
1 reference
1 reference
Identifiers
1 reference